MMI Monthly: Public Health Stories from Bench to Breakthrough

MMI Monthly: Public Health Stories from Bench to Breakthrough
Podcast Description
MMI Monthly's podcast, "Public Health Stories from Bench to Breakthrough," highlights scientific research and advances in the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health.
Podcast Insights
Content Themes
The podcast focuses on themes related to public health advancements and scientific research, with episode highlights that include discussions on the integration of philosophy in science education and the journey of COVID-19 convalescent plasma therapy from emergency use to FDA approval, emphasizing the importance of rigorous scientific inquiry and learning from historical experiences.

MMI Monthly’s podcast, “Public Health Stories from Bench to Breakthrough,” highlights scientific research and advances in the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health.
Watch the video version: https://youtu.be/pnnWWDf6U9o?si=CHmOTsWBWLZkpU7N
Why do women tend to have stronger immune responses than men? From COVID-19 to influenza, Johns Hopkins researcher Prof. Sabra Klein explains the biological and social factors that shape how we fight disease. Discover the latest science behind sex differences in immunity—and what it means for the future of medicine.
Guest: Prof. Sabra Klein, Professor, Johns Hopkins Bloomberg School of Public Health
A production of MMI Monthly – From Bench to Breakthrough

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.